Overview
This study aims to evaluate the affection of symptoms duration on outcomes of lumbar spine surgery.
Description
Lumbar spine surgery is a pivotal intervention for a variety of conditions affecting the lower back, such as degenerative disc disease, spinal stenosis, spondylolisthesis, and disc herniation.
The first line of treatment in lumbar spine is usually conservative. If conservative treatment fails to lead to an improvement in symptoms in 3 to 6 months, surgical treatment can be considered as an option for symptom relief. Invasive therapies are considered when neurogenic claudication is present with positive findings from diagnostic imaging. Surgery has been shown to provide better outcomes for at least 4 years in terms of disability and pain with a narrowing of the benefits over time compared with conservative treatment.
Eligibility
Inclusion Criteria:
- Age ≥18 years old.
- Both sexes.
- Patients undergoing lumbar spine surgery
- Presenting symptoms include lumbar back pain, lumbar radiculopathy, neurogenic claudication, lower-extremity weakness, bowel or bladder symptoms, and duration of symptoms.
Exclusion Criteria:
- Previous spinal surgery.
- Vascular claudication.
- Comorbid pathology affecting walking ability.
- Severe comorbidities that may impact surgery outcomes (e.g., uncontrolled diabetes, cardiovascular disease).
- Bony metastases.
- Unfit for general anaesthesia.